Feature Review,IGF-1 is a peptide hormone

The question of is IGF-1 a steroid or peptide is a common one, particularly within discussions of athletic performance, bodybuilding, and hormone therapy. To clarify this, it's essential to understand the distinct biological classifications and functions of these molecules. IGF-1, which stands for Insulin-like Growth Factor 1, is definitively not a steroid. Instead, it is classified as a peptide hormone. This distinction is crucial as steroids and peptides operate through different mechanisms and have unique molecular structures.

IGF-1 is a hormone produced naturally within the human body, primarily in the liver, in response to growth hormone (GH). Its molecular structure is characterized by a chain of amino acids, classifying it as a polypeptide or a protein-peptide hormone. Specifically, IGF-1 is a 70-amino acid single-chain peptide with a molecular weight of approximately 7.6 kDa. It contains three disulfide bridges, contributing to its specific three-dimensional structure and function. This structure is fundamentally different from that of steroids, which are derived from a four-ring carbon structure.

The role of IGF-1 in the body is multifaceted. It is a critical mediator of the effects of growth hormone, playing a significant role in childhood growth and development. In adults, IGF-1 continues to be important for cellular repair, tissue maintenance, and metabolic regulation. It acts as a signaling molecule, binding to IGF-1 receptors on various cells, including muscle cells, to stimulate processes like protein synthesis and cell proliferation. This makes it a potent mitogenic agent that mediates the intended effects of GH.

In contrast, anabolic steroids are synthetic derivatives of testosterone. They primarily function by increasing protein synthesis within cells, leading to increased muscle mass and strength. While both IGF-1 and anabolic steroids can contribute to muscle growth, their mechanisms of action and chemical compositions are entirely different. The World Anti-Doping Agency (WADA) lists IGF-1 under the class of peptide hormones, growth factors, and related substances, indicating its distinct classification from prohibited steroids.

The confusion may arise because both IGF-1 and certain steroids are sometimes misused by athletes seeking to enhance performance. However, it is important to reiterate that IGF-1 is a naturally occurring peptide hormone, not a steroid. Its administration, particularly in forms like IGF-1 LR3 (a longer-acting analog) or IGF-1 DES, is considered a form of performance-enhancing drug (PED) use in competitive sports due to its potent anabolic effects. IGF-1 DES is not just a bodybuilding peptide; it is also recognized for its potential in tissue regeneration and injury recovery.

The molecule is also sometimes referred to as somatomedin C or somatomedin. Its molecular structure is similar in some ways to insulin, hence the name insulin-like growth factor 1. This similarity to insulin is primarily in its molecular structure and its involvement in metabolic processes.

Understanding whether IGF-1 is a steroid or peptide is vital for accurate biological and medical contexts. As established, IGF-1 is a peptide hormone, a naturally occurring substance with significant physiological roles. While its potent effects have led to its inclusion on prohibited substance lists in sports, this does not alter its fundamental classification as a peptide and not a steroid. The scientific community and regulatory bodies clearly define IGF-1 as a peptide.